Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

612 trials

NCT07799961
Recruiting
Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
Not applicable · United States · 2 sites
Registry update: 2 Sept 2026
NCT06647888
Recruiting
Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
Not applicable · South Korea · 1 site
Registry update: 23 Jan 2025
NCT06703151
Recruiting
To Understand the Self-care Ability of Farmers and Fishermen With CMDs (Hypertension, Heart Disease, Hyperlipidemia, Type 2 Diabetes), Whether They Are Aware of CMDs, Their Treatment Status, Treatment Effectiveness, and Their Ability to Describe Known and Practice the Self-care Content of CMDs.
Not applicable · Taiwan · 1 site
Registry update: 12 Feb 2025
NCT06643130
Recruiting
Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
Phase 3 · South Korea · 1 site
Registry update: 9 Sept 2025
NCT06059144
Recruiting
Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine
Phase 3 · France · 1 site
Registry update: 9 Jan 2025
NCT06693934
Recruiting
Jockey Club Precision Prevention Programme on Young Onset Diabetes
Not applicable · Hong Kong · 1 site
Registry update: 19 Mar 2025
NCT06513975
Recruiting
Validation Study of CART BP as a Wearable Cuffless Blood Pressure Monitor
Not applicable · South Korea · 1 site
Registry update: 15 Jun 2025
NCT06526858
Recruiting
Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension
Not applicable · United States · 6 sites
Registry update: 10 Aug 2026
NCT06511479
Recruiting
Jackson Heart Study Women's Hypertension Study
Not applicable · United States · 1 site
Registry update: 25 Feb 2026
NCT06343298
Recruiting
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Phase 2 · United States · 23 sites
Registry update: 23 Sept 2026
NCT06803849
Recruiting
Association of Heterogeneous Circulating Biomarkers and Anamnestic Factors of Pregnancy Adverse Course and Outcomes With the Prognosis of Heart Failure With Preserved Ejection Fraction
Not applicable · Russia · 1 site
Registry update: 31 Jan 2025
NCT06669715
Recruiting
Evaluation of Physical Fitness and Hemodynamics Across a Diverse Population
Not applicable · Slovenia · 1 site
Registry update: 12 May 2026
NCT05903950
Recruiting
Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure
Not applicable · Qatar · 1 site
Registry update: 23 Oct 2026
NCT06694012
Recruiting
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
Not applicable · Japan · 1 site
Registry update: 4 Dec 2024
NCT06655675
Recruiting
Changes in Velocimetric Indices of Uterine and Umbilical Arteries Before and After Combined Spinal-epidural Analgesia in Laboring Women (PART II)
Not applicable · Canada · 1 site
Registry update: 11 Jul 2025
NCT06220721
Recruiting
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
Not applicable · United States · 2 sites
Registry update: 20 Jul 2026
NCT06740838
Recruiting
Overnight Dexamethasone in Primary Aldosteronism Screening
Not applicable · Poland · 1 site
Registry update: 2 Oct 2025
NCT07263490
Recruiting
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
Not applicable · Denmark · 6 sites
Registry update: 13 Apr 2026
NCT06468202
Recruiting
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Phase 4 · United States · 20 sites
Registry update: 27 Oct 2026
NCT06676553
Recruiting
INtraprocedural Feedback-Optimized Renal Denervation Based on Measurements Obtained Through Renal Artery Stimulation: a Randomized Controlled Trial (INFORM)
Phase 4 · Taiwan · 1 site
Registry update: 6 Nov 2024

Ordered by registry start date. Freshness and sponsorship never change the order.